Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations

v3.7.0.1
Consolidated Statement of Operations - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Net revenue $ 104,175,000 $ 101,687,000 $ 193,016,000 $ 204,372,000
Cost of net revenue 53,071,000 38,774,000 88,988,000 80,289,000
Gross profit 51,104,000 62,913,000 104,028,000 124,083,000
Operating expenses:        
Research and development 29,015,000 24,037,000 52,893,000 47,789,000
Selling, general and administrative 31,338,000 16,505,000 49,951,000 30,115,000
IPR&D impairment losses     0  
Restructuring charges 6,546,000 0 6,546,000 2,106,000
Total operating expenses 66,899,000 40,542,000 109,390,000 80,010,000
Income (loss) from operations (15,795,000) 22,371,000 (5,362,000) 44,073,000
Interest income 64,000 167,000 259,000 337,000
Interest Expense 2,201,000 0 2,201,000 0
Other Nonoperating Income (Expense) (618,000) 124,000 (762,000) (74,000)
Nonoperating Income (Expense) (2,755,000) 291,000 (2,704,000) 263,000
Income (loss) before income taxes (18,550,000) 22,662,000 (8,066,000) 44,336,000
Income tax provision (benefit) (29,515,000) 78,000 (27,494,000) 1,071,000
Net income (loss) $ 10,965,000 $ 22,584,000 $ 19,428,000 $ 43,265,000
Net income per share:        
Basic $ 0.17 $ 0.36 $ 0.30 $ 0.69
Diluted $ 0.16 $ 0.33 $ 0.28 $ 0.64
Shares used to compute net income per share:        
Basic 65,889 63,470 65,564 63,056
Diluted 69,645 67,520 69,398 67,110